This project aims to determine the efficacy of our palbociclib-bortezomib clinical trial in mantle cell lymphoma, based on preclinical studies that have shown enhanced killing of MCL and myeloma cells
1. Today (2024-06-27), we discovered an issue with the labeling of sample groups in one of the supplementary figures (Supplementary Figure 14c) in our published article. We have corrected the figure a
Genes whose expression is elevated in Breast cancer as compared to other cancers, based on TCGA data. Genes with a favourable pathology prognostics are colored in green while unfavourable genes are co
Soft-tissue sarcomas are group of rare, tremendously heterogeneous, and highly aggressive malignancies. Characterizing inter-tumor heterogeneity is crucial for selecting suitable sarcoma therapy, as t
